3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
49
Neoplasms
36
Prostatic Neoplasms
25
Carcinoma, Non-Small-Cell Lung
25
Polycystic Ovary Syndrome
16
Pain
15
Keratosis, Actinic
14
Leukemia
12
Colorectal Neoplasms
11
Uterine Cervical Neoplasms
10
Pancreatic Neoplasms
10
Lung Neoplasms
10
Leiomyoma
10
Carcinoma, Hepatocellular
10
Ovarian Neoplasms
9
Neoplasm Metastasis
9
Lymphoma, Follicular
9
Carcinoma, Renal Cell
9
Brain Neoplasms
9
Neuroendocrine Tumors
8
Arthritis, Rheumatoid
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Melanoma
7
Kidney Neoplasms
7
Head and Neck Neoplasms
7
Colonic Neoplasms
7
Cancer Pain
7
Multiple Myeloma
6
Lymphoma
6
Liver Neoplasms
6
Interventions
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Has results
×
Systemic Inflammatory Response Syndrome
×
Clear all
NCT03125941
2019-12-02
DEX-MAS
Rigshospitalet, Denmark
Phase 4
Completed
130 enrolled
20 charts